Illumina Inc. (ILMN) Shares See Target Boost as Analysts See Potential 2026 Upside

TheFly reported connected January 7 that TD Cowen raised its terms people connected ILMN to $140 from $115 portion maintaining a Hold rating. The alteration was included successful the company’s outlook for the beingness subject tools manufacture for the 4th quarter. Although respective firms person already released cautious proposal for 2026, the expert pointed retired that caller stock terms advances person elevated expectations. TD Cowen feels this leaves abstraction for upside adjacent year.

Separately, connected January 6, Illumina Inc. (NASDAQ:ILMN) launched Illumina Connected Multiomics, a cloud-based level designed to integrate and analyse ample multiomic datasets.

Illumina Inc. (NASDAQ:ILMN) develops precocious genomic sequencing and multiomics solutions, enabling precision oncology research, biomarker discovery, and targeted therapies. Its AI-driven platforms accelerate crab diagnostics, cause development, and personalized attraction strategies, positioning the institution arsenic a person successful oncology-focused genomic innovation.

While we admit the imaginable of ILMN arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 12 Best Multibagger Stocks to Buy Heading into 2026 and 7 Best Rising Tech Stocks to Buy Now.

Disclosure: None.